The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion (the CIRANO study)

International Archives of Allergy and Immunology

Volumn 158, Issue 2, 2012, Pages 184-190

  Guilemany, José Maria ^a,c   García Piñero, Alfons ^a,c   Alobid, Isam ^a,c   Centellas, Silvia ^a,c   Mariño, Franklin Santiago ^a   Valero, Antonio ^a,c   Bernal Sprekelsen, Manuel ^a,c   Picado, César ^a,b,c   Mullol, Joaquim ^a,b,c  

^a HOSPITAL CLÍNIC   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Levocetirizine; Olfaction; Persistent allergic rhinitis

Indexed keywords

LEVOCETIRIZINE; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; BARCELONA SMELL TEST 24; CAST APPLICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FEMALE; HUMAN; MALE; NOSE CONGESTION; OLFACTOMETRY; PRICK TEST; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RHINOMETRY; RHINORRHEA; SINUSITIS; SMELLING DISORDER; SNEEZING; THERAPY EFFECT; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADULT; CETIRIZINE; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; INFLAMMATION; MALE; NITRIC OXIDE; OLFACTION DISORDERS; PLACEBOS; RHINITIS, ALLERGIC, SEASONAL; SMELL;

EID: 84856203390     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000331329     Document Type: Article

References (27)

1. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, Williams H, ISAAC Phase Three Study Group: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry crosssectional surveys. Lancet 2006; 368: 733-743. (Pubitemid 44279052)
2. Bousquet J, Khaltaev N, Cruz A, Denburg J, Fokkens W, Togias A, et al: ARIA update (in collaboration with GA 2 LEN and AllerGen). Allergy 2008; 63: 8-160.
3. Lane AP, Zweiman B, Lanza DC, Swift D, Doty R, Dhong HJ, Kennedy DW: Acoustic rhinometry in the study of the acute nasal allergic response. Ann Otol Rhinol Laryngol 1996; 105: 811-818. (Pubitemid 26346565)
4. Hinriksdottir I, Murphy C, Bende M: Olfactory threshold after nasal allergen challenge. ORL J Otorhinolaryngol Relat Spec 1997; 59: 36-38. (Pubitemid 27129947)
5. Klimek L, Eggers G: Olfactory dysfunction in allergic rhinitis is related to nasal eosinophilic inflammation. J Allergy Clin Immunol 1997; 100: 158-164. (Pubitemid 27349854)
6. Meltzer EO, Jalowayski AA, Orgel HA, Harris AG: Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with momethasone fuorate nasal spray. J Allergy Clin Immunol 1998; 102: 39-49. (Pubitemid 28345783)
7. Simola M, Malmberg H: Sense of smell in allergic and nonallergic rhinitis. Allergy 1998; 53: 190-194. (Pubitemid 28341491)
8. Moll B, Klimek L, Eggers G, Mann W: Comparison of olfactory function in patients with seasonal and perennial allergic rhinitis. Allergy 1998; 53: 297-301. (Pubitemid 28125934)
9. Apter AJ, Mott AE, Frank ME, Clive JM: Allergic rhinitis and olfactory loss. Ann Allergy Asthma Immunol 1995; 75: 311-316.
10. Apter AJ, Gent JF, Frank ME: Fluctuating olfactory sensitivity and distorted odor perception in allergic rhinitis. Arch Otolaryngol Head Neck Surg 1999; 125: 1005-1010. (Pubitemid 29424734)
11. Cowart BJ, Flynn-Rodden K, Mc Gready SL: Hyposmia in allergic rhinitis. J Allergy Clin Immunol 1993; 91: 747-751. (Pubitemid 23110720)
12. Rydzewski B, Pruszewicz A, Sulkowski WJ: Assessment of smell and taste in patients with allergic rhinitis. Acta Otolaryngol 2000; 120: 323-326.
13. Higo R, Ichimura K, Ota Y, Ishizuka T, Shimazoki Y: Investigation of 'anosmic zones'associated with nasal allergy (in Japanese). Nippon Jibiinkoka Gakkai Kaiho 1996; 99: 1648-1652. (Pubitemid 126508434)
14. Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, Valero A, Picado C, Mullol J: Persistent allergic rhinitis has a moderate impact on the sense of smell depending on both nasal congestion and inflammation. Laryngoscope 2009; 119: 233-238.
15. Hilberg O: Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge. Allergy 1995; 50: 683-688.
16. Bachert C, Bousquet J, Canonica GW, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, Van Hammée G, XPERT Study Group: Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004; 114: 838-844. (Pubitemid 39330255)
17. Walter Canonica G, Bousquet J, Van Hammée G, Bachert C, Durham SR, Klimek L, Mullol J, Van Cauwenberge PB, XPERT Study Group: Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 2006; 100: 1706-1715. (Pubitemid 44283765)
18. Bousquet J, Demarteau N, Mullol J, van den Akker-van Marle ME, Van Ganse E, Bachert C, XPERT study group: Costs associated with persistent allergic rhinitis are reduced by levocetirizine. Allergy 2005; 60: 788-794.
19. Devalia JL, De Vos C, Hanotte F, Baltes E: A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers. Allergy 2001; 56: 50-57. (Pubitemid 32099072)
20. Stübner P, Zieglmayer R, Horak F: A direct comparison of the efficacy of antihistamines in SAR and PAR: randomised, placebo-controlled studies with levocetirizine and loratadine using an environmental exposure unit -the Vienna Challenge Chamber (VCC). Curr Med Res Opin 2004; 20: 891-902. (Pubitemid 38821528)
21. Cardesín A, Alobid I, Benítez P, Sierra E, de Haro J, Bernal-Sprekelsen M, Picado C, Mullol J: Barcelona Smell Test-24 (BAST-24): validation and smell characteristics in the healthy Spanish population. Rhinology 2006; 44: 83-89. (Pubitemid 43379725)
22. Serrano C, Valero A, Bartra J, Torrego T, Mullol J, Picado C: Effects on nasal nitric oxide production of 2 mechanisms of vasoconstriction. J Investig Allergol Clin Immunol 2007; 17: 337-340. (Pubitemid 350012549)
23. Valero A, Serrano C, Valera JL, Barberá A, Torrego A, Mullol J, Picado C: Nasal and bronchial response to exercise in patients with asthma and rhinitis: the role of nitric oxide. Allergy 2005; 60: 1126-1131. (Pubitemid 41153138)
24. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ: Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996; 98: 843-845. (Pubitemid 26357253)
25. Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Lorber R, Zuberbier T, ACCEPT-2 study group: Efficacy of desloratadine in persistent allergic rhinitis: a GA 2 LEN study. Int Arch Allergol Immunol 2010; 153: 395-402.
26. Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Bindslev Jensen C, Fokkens WJ, Ring J, Keith P, Lorber R, Zuberbier T, ACCEPT-1 study group: Efficacy of desloratadine in intermittent allergic rhinitis: a GA 2 LEN study. Allergy 2009; 64: 1516-1523.
27. Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group: A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Allergy 2008; 63: 924-931. (Pubitemid 351832790)